HUTCHMED (China) Limited (ADR)
General ticker "HCM" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $3.4B (TTM average)
HUTCHMED (China) Limited (ADR) does not follow the US Stock Market performance with the rate: -17.7%.
Estimated limits based on current volatility of 2.0%: low 13.55$, high 14.10$
Factors to consider:
- Total employees count: 1796 (-0.8%) as of 2025
- Current price 20.2% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [16.76$, 27.55$]
- 2025-12-31 to 2026-12-31 estimated range: [17.61$, 28.88$]
Financial Metrics affecting the HCM estimates:
- Positive: with PPE of 73.6 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 0.02 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -6.49
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 2.91
- Positive: Industry inventory ratio change (median), % of -1.31 <= -0.92
- Negative: Inventory ratio change, % of 8.28 > 4.02
- Positive: -4.49 < Investing cash flow per share per price, % of -3.92
- Positive: 58.56 < Shareholder equity ratio, % of 59.64 <= 69.38
- Negative: 0.07 < Interest expense per share per price, % of 0.12
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term HCM quotes
Long-term HCM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $838.00MM | $630.20MM | $549.96MM |
| Operating Expenses | $819.62MM | $673.91MM | $604.69MM |
| Operating Income | $18.38MM | $-43.70MM | $-54.73MM |
| Non-Operating Income | $87.23MM | $89.07MM | $577.45MM |
| Interest Expense | $0.76MM | $2.87MM | $2.87MM |
| R&D Expense | $303.06MM | $213.37MM | $164.15MM |
| Income(Loss) | $105.60MM | $45.36MM | $522.72MM |
| Taxes | $4.51MM | $7.19MM | $63.78MM |
| Net Income(Loss)* | $100.78MM | $37.73MM | $458.12MM |
| Stockholders Equity | $730.54MM | $759.93MM | $1,237.93MM |
| Inventory | $50.26MM | $50.40MM | $41.13MM |
| Assets | $1,279.77MM | $1,274.20MM | $1,753.10MM |
| Operating Cash Flow | $219.26MM | $0.50MM | $-64.66MM |
| Capital expenditure | $32.61MM | $17.93MM | $24.15MM |
| Investing Cash Flow | $-291.14MM | $-96.06MM | $-29.41MM |
| Financing Cash Flow | $48.66MM | $-30.67MM | $7.84MM |
| Earnings Per Share** | $0.59 | $0.22 | $2.67 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.